FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3004497148> ?p ?o ?g. }

• W3004497148 endingPage "7083" @default.
• W3004497148 startingPage "7074" @default.
• W3004497148 abstract "Ulcerative colitis (UC) is a chronic inflammatory intestinal disease, and its morbidity is rising worldwide. Previous study indicated that astragaloside II (AS II), a monomeric compound, was used to treat bowel disease. However, the effects of AS II on UC remains unclear. Thus, this study aimed to investigate the therapeutic effects of AS II on experimental UC in vitro and in vivo.CCD-18Co cells were stimulated by 1 μg/mL LPS to mimic UC in vitro. In addition, dextran sulfate sodium (DSS)-induced UC mouse model was established in vivo. CCK-8 assay was used to detect cell proliferation in vitro. Moreover, the concentrations of inflammatory factors interleukin 6 (IL-6), tumor necrosis factor-α (TNF-α), interleukin 1β (IL-1β), nitric oxide (NO), superoxide dismutase (SOD) and malondialdehyde (MDA) in CCD-18Co cells and colon tissues were determined by ELISA, respectively. Meanwhile, the expressions of hypoxia-inducible factor 1α (HIF-α), phospho-inhibitor of NF-κB (p-IκB) and phospho-NF-κB p65 (p-p65) were detected by western blotting in vitro and in vivo, respectively.In this study, the levels of pro-inflammatory cytokines TNF-α, IL-1β and IL-6 were significantly increased in lipopolysaccharide (LPS)-stimulated CCD-18Co cells. However, LPS-induced inflammatory response was markedly alleviated by AS II. In addition, LPS-induced HIF-α, p-IκB and p-p65 proteins increases were markedly ameliorated by AS II treatment. Moreover, AS II reduced disease activity index (DAI) scores and increased the colon lengths in DSS-treated mice. Meanwhile, AS II decreased the levels of IL-6, TNF-α, IL-1β, NO, MPO and MDA, and increased the level of SOD in colon of DSS-treated mice. Furthermore, AS II downregulated the expressions of HIF-α, p-IκB and p-p65 in DSS-induced UC in mice.Our findings indicated that AS II could alleviate inflammatory response in LPS-induced CCD-18Co cells and in DSS-induced UC in mice. In conclusion, AS II may serve as a potential agent for the treatment of UC." @default.
• W3004497148 created "2020-02-14" @default.
• W3004497148 creator A5025933863 @default.
• W3004497148 creator A5028695905 @default.
• W3004497148 creator A5040746607 @default.
• W3004497148 creator A5044997577 @default.
• W3004497148 creator A5055149115 @default.
• W3004497148 creator A5061390550 @default.
• W3004497148 creator A5076930880 @default.
• W3004497148 creator A5078739680 @default.
• W3004497148 creator A5082069136 @default.
• W3004497148 date "2019-01-01" @default.
• W3004497148 modified "2023-09-26" @default.
• W3004497148 title "Astragaloside II alleviates the symptoms of experimental ulcerative colitis in vitro and in vivo." @default.
• W3004497148 cites W1512327653 @default.
• W3004497148 cites W1597959509 @default.
• W3004497148 cites W1844541808 @default.
• W3004497148 cites W1863597969 @default.
• W3004497148 cites W1919312985 @default.
• W3004497148 cites W1971903571 @default.
• W3004497148 cites W1980018183 @default.
• W3004497148 cites W1992317509 @default.
• W3004497148 cites W2025371570 @default.
• W3004497148 cites W2041316901 @default.
• W3004497148 cites W2073701670 @default.
• W3004497148 cites W2097784885 @default.
• W3004497148 cites W2112055616 @default.
• W3004497148 cites W2120522488 @default.
• W3004497148 cites W2140855200 @default.
• W3004497148 cites W2162121911 @default.
• W3004497148 cites W2165523086 @default.
• W3004497148 cites W2171398625 @default.
• W3004497148 cites W2336089931 @default.
• W3004497148 cites W2536753757 @default.
• W3004497148 cites W2591602808 @default.
• W3004497148 cites W2747246230 @default.
• W3004497148 cites W2755821913 @default.
• W3004497148 cites W2767791562 @default.
• W3004497148 cites W2795170827 @default.
• W3004497148 cites W2890529309 @default.
• W3004497148 cites W2902066950 @default.
• W3004497148 cites W2904030626 @default.
• W3004497148 cites W2904178965 @default.
• W3004497148 cites W2904693977 @default.
• W3004497148 cites W2905687525 @default.
• W3004497148 cites W2905904590 @default.
• W3004497148 cites W2912750647 @default.
• W3004497148 cites W2916106050 @default.
• W3004497148 cites W2950945243 @default.
• W3004497148 cites W2992213063 @default.
• W3004497148 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6895531" @default.
• W3004497148 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31814910" @default.
• W3004497148 hasPublicationYear "2019" @default.
• W3004497148 type Work @default.
• W3004497148 sameAs 3004497148 @default.
• W3004497148 citedByCount "5" @default.
• W3004497148 countsByYear W30044971482021 @default.
• W3004497148 countsByYear W30044971482022 @default.
• W3004497148 countsByYear W30044971482023 @default.
• W3004497148 crossrefType "journal-article" @default.
• W3004497148 hasAuthorship W3004497148A5025933863 @default.
• W3004497148 hasAuthorship W3004497148A5028695905 @default.
• W3004497148 hasAuthorship W3004497148A5040746607 @default.
• W3004497148 hasAuthorship W3004497148A5044997577 @default.
• W3004497148 hasAuthorship W3004497148A5055149115 @default.
• W3004497148 hasAuthorship W3004497148A5061390550 @default.
• W3004497148 hasAuthorship W3004497148A5076930880 @default.
• W3004497148 hasAuthorship W3004497148A5078739680 @default.
• W3004497148 hasAuthorship W3004497148A5082069136 @default.
• W3004497148 hasConcept C126322002 @default.
• W3004497148 hasConcept C150903083 @default.
• W3004497148 hasConcept C17991360 @default.
• W3004497148 hasConcept C185592680 @default.
• W3004497148 hasConcept C202751555 @default.
• W3004497148 hasConcept C203014093 @default.
• W3004497148 hasConcept C207001950 @default.
• W3004497148 hasConcept C2775838275 @default.
• W3004497148 hasConcept C2775862500 @default.
• W3004497148 hasConcept C2776151105 @default.
• W3004497148 hasConcept C2778260677 @default.
• W3004497148 hasConcept C2778401633 @default.
• W3004497148 hasConcept C2778690821 @default.
• W3004497148 hasConcept C2778754761 @default.
• W3004497148 hasConcept C2779134260 @default.
• W3004497148 hasConcept C2780479503 @default.
• W3004497148 hasConcept C519581460 @default.
• W3004497148 hasConcept C55493867 @default.
• W3004497148 hasConcept C71924100 @default.
• W3004497148 hasConcept C74172505 @default.
• W3004497148 hasConcept C86803240 @default.
• W3004497148 hasConcept C98274493 @default.
• W3004497148 hasConceptScore W3004497148C126322002 @default.
• W3004497148 hasConceptScore W3004497148C150903083 @default.
• W3004497148 hasConceptScore W3004497148C17991360 @default.
• W3004497148 hasConceptScore W3004497148C185592680 @default.
• W3004497148 hasConceptScore W3004497148C202751555 @default.
• W3004497148 hasConceptScore W3004497148C203014093 @default.
• W3004497148 hasConceptScore W3004497148C207001950 @default.

• next